[go: up one dir, main page]

EP1993591A4 - Administration ciblee de composes pharmaceutiques - Google Patents

Administration ciblee de composes pharmaceutiques

Info

Publication number
EP1993591A4
EP1993591A4 EP07757643A EP07757643A EP1993591A4 EP 1993591 A4 EP1993591 A4 EP 1993591A4 EP 07757643 A EP07757643 A EP 07757643A EP 07757643 A EP07757643 A EP 07757643A EP 1993591 A4 EP1993591 A4 EP 1993591A4
Authority
EP
European Patent Office
Prior art keywords
targeted delivery
pharmaceutical compounds
pharmaceutical
compounds
targeted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07757643A
Other languages
German (de)
English (en)
Other versions
EP1993591A2 (fr
Inventor
Alfred Stracher
Leo Kesner
Abraham Shulman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of EP1993591A2 publication Critical patent/EP1993591A2/fr
Publication of EP1993591A4 publication Critical patent/EP1993591A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP07757643A 2006-02-28 2007-02-28 Administration ciblee de composes pharmaceutiques Withdrawn EP1993591A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77759906P 2006-02-28 2006-02-28
PCT/US2007/062982 WO2007101252A2 (fr) 2006-02-28 2007-02-28 Administration ciblee de composes pharmaceutiques

Publications (2)

Publication Number Publication Date
EP1993591A2 EP1993591A2 (fr) 2008-11-26
EP1993591A4 true EP1993591A4 (fr) 2009-08-19

Family

ID=38459814

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07757643A Withdrawn EP1993591A4 (fr) 2006-02-28 2007-02-28 Administration ciblee de composes pharmaceutiques

Country Status (4)

Country Link
US (1) US8729024B2 (fr)
EP (1) EP1993591A4 (fr)
CA (1) CA2643111A1 (fr)
WO (1) WO2007101252A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2643111A1 (fr) 2006-02-28 2007-09-07 The Research Foundation Of State University Of New York Administration ciblee de composes pharmaceutiques

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050004177A1 (en) * 2003-07-02 2005-01-06 Warner-Lambert Company Llc Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
WO2005124563A2 (fr) * 2004-06-12 2005-12-29 Ceptor Corporation Composes et kits de traitement de troubles musculaires et procedes d'utilisation de ceux-ci

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008288A (en) * 1986-01-06 1991-04-16 Alfred Stracher Carnitine directed pharmaceutical agents
US7060708B2 (en) * 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US7691962B2 (en) 2004-05-19 2010-04-06 Medarex, Inc. Chemical linkers and conjugates thereof
CA2643111A1 (fr) 2006-02-28 2007-09-07 The Research Foundation Of State University Of New York Administration ciblee de composes pharmaceutiques

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050004177A1 (en) * 2003-07-02 2005-01-06 Warner-Lambert Company Llc Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
WO2005124563A2 (fr) * 2004-06-12 2005-12-29 Ceptor Corporation Composes et kits de traitement de troubles musculaires et procedes d'utilisation de ceux-ci

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BELLIOTTI THOMAS R ET AL: "Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein", JOURNAL OF MEDICINAL CHEMISTRY, vol. 48, no. 7, April 2005 (2005-04-01), pages 2294 - 2307, XP002535229, ISSN: 0022-2623 *
RAY SWAPAN K ET AL: "CALPAIN AND ITS INVOLVEMENT IN THE PATHOPHYSIOLOGY OF CNS INJURIES AND DISEASES: THERAPEUTIC POTENTIAL OF CALPAIN INHIBITORS FOR PREVENTION OF NEURODEGENERATION", CURRENT DRUG TARGETS. CNS & NEUROLOGICAL DISORDERS, BENTHAM SCIENCE PUBLISHERS, HILVERSUM, NL, vol. 2, no. 3, 1 June 2003 (2003-06-01), pages 173 - 189, XP009072337, ISSN: 1568-007X *

Also Published As

Publication number Publication date
US20090227522A1 (en) 2009-09-10
EP1993591A2 (fr) 2008-11-26
WO2007101252A2 (fr) 2007-09-07
US8729024B2 (en) 2014-05-20
CA2643111A1 (fr) 2007-09-07
WO2007101252A3 (fr) 2007-12-06

Similar Documents

Publication Publication Date Title
EP2219725A4 (fr) Manchon d'administration de médicament
EP2361647A4 (fr) Dispositif d'administration de médicament
DK2692341T3 (da) Misbrugs-resistent lægemiddelformulering
IL193727A0 (en) Dosage forms for administering combinations of drugs
EP2132133A4 (fr) Administration de médicament particulaire
EP1981527A4 (fr) Administration thermiquement ciblee de medicaments comme la doxorubicine
EP2421587A4 (fr) Dispositif d'administration de médicament
EP2313122A4 (fr) Dispositif médical d administration de médicament
BRPI0716196A2 (pt) Sistemas de distribuição de fármacos que compreendem soluções sólidas de fármacos fracamente básicos.
IL227898A (en) A drug delivery system with a small amount of drug component
BRPI0916877A2 (pt) composição farmacêutica e administração da mesma
EP2643009A4 (fr) Composition d'administration de médicament biodégradable
PL2464342T3 (pl) Formulacje farmaceutyczne do zapobiegania niewłaściwemu użyciu leków medycznych
DK2080514T3 (da) Manipulationssikre orale farmaceutiske doseringsformer omfattende et opioidanalgetikum
EP2411083A4 (fr) Dispositif médical d'administration de médicament
BRPI0818129A2 (pt) Sistema de transporte e administração de medicamento seguro
CY2019021I2 (el) Συστημα χορηγησης φαρμακων για τη χορηγηση πτωχως υδατοδιαλυτων φαρμακευτικως ενεργων ουσιων
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
ZA200808114B (en) Formulations of low dose non-steroidal anti-inflammatory drugs and betacyclodextrin
EP2154966A4 (fr) Benzimidazoles et compositions pharmaceutiques de ceux-ci
EP2226083A4 (fr) Système d'administration de médicament
EP2632902A4 (fr) Système amélioré d'administration ciblée de médicaments par voie orale
BRPI0923675A2 (pt) formulação para administração de medicamento com baixa quantidade de lipídeos por via transmucosal oral
BRPI0922888A2 (pt) administração combinada de fármaco
EP1977766A4 (fr) Materiau de distribution de medicament

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080918

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20090720

17Q First examination report despatched

Effective date: 20091023

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100504